Talk:VBI Vaccines
Latest comment: 2 years ago by 2pou in topic Requested move 31 December 2021
This is the talk page for discussing improvements to the VBI Vaccines article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Requested move 31 December 2021
edit- The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this section.
It was proposed in this section that Variation Biotechnologies be renamed and moved to VBI Vaccines.
result: Links: current log • target log
This is template {{subst:Requested move/end}} |
Variation Biotechnologies → VBI Vaccines – Most references use the name, VBI Vaccines Inc. (Nasdaq: VBIV), a holding company, rather than Variation Biotechnologies, an operating company. Eastmain (talk • contribs) 04:25, 31 December 2021 (UTC)
The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.